Podcasts about personalizing

Not all patients are the same, so why should their prevention strategies be? Credit available for this activity expires: 6/11/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/episode-6-personalizing-cardiovascular-prevention-methods-2026a1000eep?ecd=bdc_podcast_libsyn_mscpedu

A deep dive into the astrology forecast for June 2026, with astrologers Chris Brennan and Leisa Schaim. We spend the first hour talking about the astrology behind news and events that happened since our last forecast, and then in the second hour we get into the astrology of June. The month opens with one of the most auspicious planetary alignments of the year: a Venus-Jupiter conjunction in Cancer that remains active for the first two weeks. Venus-Jupiter conjunctions are excellent for relationships, marriages, and partnerships, as well as peacekeeping efforts and the confirmation of good things. In the middle of the month, there is a distinct tone shift when Venus enters Leo and begins opposing Pluto. This aspect can bring up issues related to power, manipulation, and control within the context of partnerships and relationships. At the same time, Mercury enters its shadow period, slowing down and preparing to station retrograde, while Mars moves within a 10-degree orb of a volatile conjunction with Uranus. The latter part of the month takes an unexpected and explosive turn, especially once Mars officially enters Gemini and the conjunction with Uranus tightens. On the final day of the month, Jupiter enters Leo, beginning a one-year transit through that sign. However, this transit starts with an opposition to Pluto that will culminate in July, highlighting themes involving the manipulation of truth and attempts to control knowledge. Simultaneously, Mercury stations retrograde just before it can reach a conjunction with Jupiter, effectively revoking and delaying a beneficent alignment just as the much more malefic Mars-Uranus configuration is forming. This is episode 538 of The Astrology Podcast. LA Astro Fest https://laastrofest.com Astrocartography Petitions https://www.astrologicalassociation.com/astrocartography-petition/ https://www.change.org/p/protégeons-l-astrocartographie Leisa's Website https://www.leisaschaim.com 2026 Electional Astrology Report https://theastrologypodcast.com/2026report/ Timestamps 00:00:00 Introduction00:00:38 Quick Overview of June00:02:45 News Segment Begins00:04:01 Iran War00:12:02 Explosions Around Mars Aspects00:19:08 Hantavirus and Ebola Outbreaks00:27:53 Pope Issues AI Encyclical00:37:01 Saturn-Neptune Anti-Astrology Signature00:41:52 Trump Visits China00:49:00 Cuba00:54:01 Supreme Court Decision on Voting Rights Act01:01:32 Astrocartography Trademarking Controversy01:15:12 LA Astro Fest01:16:35 June Forecast Begins01:20:25 Mercury-Neptune Square (June 3)01:24:45 Mercury-Saturn Square01:27:56 The Venus-Jupiter Conjunction (June 9)01:41:31 Auspicious Electional Chart for June01:46:24 The World Cup & June Bright Spots01:50:10 Gemini New Moon & Mid-Month Vibe Shift01:54:41 Venus-Pluto Opposition (June 17)02:00:53 Sun Enters Cancer & Summer Solstice02:02:53 Late June Volatility & Mars-Uranus Conjunction02:04:56 Medieval Astrological Technique of "Revoking"02:06:48 Mars-Uranus in Gemini & US History02:21:40 Personalizing the Mars-Uranus Transit02:24:44 Story Time: Chris Brennan's Spicy Pepper Incident02:29:53 Jupiter Ingress into Leo (June 30)02:39:54 Final Wrap-up & Promo Outros02:43:07 End Cards Watch the Video Version of This Episode https://www.youtube.com/watch?v=ZJyrm_k3CNg - Listen to the Audio Version of This Episode Listen to the audio version of this episode or download it as an MP3:

#931 Ready to discover how interactive product demos are transforming sales, onboarding, and training? In this episode, host Kirsten Tyrrel sits down with Joseph Lee, founder of Supademo, to explore how his platform helps companies replace clunky screen recordings and outdated videos with self-guided, clickable demos. Joseph shares the journey of scratching his own entrepreneurial itch, the gap he saw in the marketplace, and why showing — not telling — is the future of product communication. From SaaS to traditional businesses, learn how Super Demo is saving time, cutting costs, and helping over 100,000 companies create engaging customer experiences! (Original Air Date - 10/1/25) What we discuss with Joseph: + Origin of Supademo + Pain points of screen recordings + Benefits of interactive demos + Sales use cases + Onboarding and training impact + Cost and time savings + Personalizing product demos + Innovative demo features + Analytics and engagement tracking + Lessons from entrepreneurship journey Thank you, Joseph! Check out Supademo at ⁠Supademo.com⁠. Follow Joseph on ⁠LinkedIn⁠. Watch the ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠video podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ of this episode! To get access to our FREE Business Training course go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠MillionaireUniversity.com/training⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. To get exclusive offers mentioned in this episode and to support the show, visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠millionaireuniversity.com/sponsors⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Learn more about your ad choices. Visit megaphone.fm/adchoices

Are we completely rewriting the playbook on how humanity eats?

Tebogo Mosweu – Founder and CEO, Ditebogo Gifts and Events SAfm Market Update - Podcasts and live stream

AI Powering the Future of Sports ExperienceIn this clip, Hugo Hamad, now Head of AI/Gen AI Factory at AXA France and former Director of AI at Decathlon, shares how AI is transforming the sports ecosystem.At its core, the mission is simple: enable everyone to engage in sports on their own terms

See what risk scores miss and apply imaging to guide real-world decisions. Credit available for this activity expires: 05/15/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/personalizing-risk-assessment-enhance-cardiovascular-2026a1000evy?ecd=bdc_podcast_libsyn_mscpedu

Melissa, Amanda, and Molly take over the OPT studio to share Q1 industry benchmarks, discuss key trends in online sales, and offer actionable advice for OSCs and leaders navigating a lower-volume, higher-quality lead environment.HousekeepingOnline Sales and Marketing Summit - Oct 1-2 - Austin, TX - We encourage OSCs to attend, with new interactive programming planned.TITO ShoutoutMonica Fikany at New Home Inc - Monica had great lead-to-appointment conversions in Q1.Danielle Evans at Bishard Holmes - 38% of Danielle's appointments came from aged leads.Key TakeawaysLead volume is down, but quality is up: The top of the funnel remains constrained, volume hasn't fully bounced back. However, conversion rates are improving, meaning OSCs are doing more with less.Prospecting is the biggest win of Q1: Normally, prospecting dips in Q1 as new leads come in during selling season. This quarter, prospecting stayed consistent and even increased -- a major highlight. The 22% age lead appointment rate is a direct result of sustained prospecting effort.Your CRM is your most valuable asset: Maximize CRM usage by logging detailed notes after every interaction - aged leads hold untapped opportunity, and leadership relies on quality CRM data to make strategic decisions, so consistency matters.Personalization wins appointments: Buyers are on a longer journey right now. Personalizing outreach and follow-up, based on good notes and CRM data, is what sets top OSCs apart.Skills CheckFor Leaders:Stop measuring program success purely on lead volume. Conversion percentages are the more meaningful metric right now. Scorecards should reflect this shift.For OSCs:Be disciplined and consistent with prospecting.Treat every lead like it's gold.Respond to new leads fast, speed to first response beats the competition.Stay process-driven: no lead left behind.

Are you underestimating what your children are capable of achieving right now? In this episode of the Homeschool Your Kids podcast, we sit down with Leah, the founder of the Society of Child Entrepreneurs, to discuss why kids don't need to wait until they are adults to start businesses and lead their communities. Learn how to stop saying no and start asking how to help your child's ideas come to life. Leah shares her incredible journey from running an in-home daycare to supporting her four-year-old daughter's first business during the 2020 lockdowns. We dive deep into the philosophy that children are not just the future, but are capable, aware leaders today. Leah explains the vital difference between child labor and child entrepreneurship, emphasizing that when kids own their successes and failures, they develop essential life skills like financial literacy, persuasive writing, and conflict resolution. From testifying at the State House for lemonade stand laws to advocating for city crosswalks, this episode is packed with inspiration for parents who want to empower their children. We also discuss Leah's 36-week entrepreneurship curriculum and how to tailor education to meet the unique needs of every child, including those with ADHD and autism. Whether your child wants to sell lemonade or launch a service-based business, this conversation provides a roadmap for nurturing the next generation of critical thinkers. https://societyofchildentrepreneurs.org/Chapters0:00 Meet Leah from the Society of Child Entrepreneurs3:20 How a four year old launched a painting business7:15 Why kids are capable leaders right now11:05 The importance of allowing kids to fail15:30 Selling specialty lemonade and hosting business fairs19:45 Testifying for lemonade stand laws in Kansas23:10 Child labor versus child entrepreneurship27:20 Why ages 8 to 13 are the perfect time to start31:45 A 36 week curriculum for young entrepreneurs35:50 Student success stories and market demand39:15 Problem spotting and monetization43:30 Civic engagement and city council advocacy47:50 Personalizing education for different learning styles51:00 Self care for parents and the joy of reading52:54 Final thoughts and encouragementIf you enjoyed this conversation, please hit the like button and subscribe for more episodes featuring real support for your homeschooling journey. Don't forget to check out the links in the description to help your kids start their own business today!

Optimize patient outcomes by selecting the right inhaler device for the right patient. Credit available for this activity expires: 4/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/right-fit-personalizing-copd-device-selection-across-patient-2026a1000dcc?ecd=bdc_podcast_libsyn_mscpedu

What if the answer to your stress…isn't doing more—but learning how to slow down?In this episode of the Walk In Victory Podcast, NaRon Tillman sits down with Veronique Ory to explore how movement, breath, and awareness can restore balance in a world built on constant motion.For many, stress shows up as tension, burnout, or disconnection—but rarely do people realize that it often begins with something as simple as not breathing properly.Through personal experience and practice, Veronique shares how yoga became more than physical movement—it became a pathway to clarity, creativity, and emotional regulation. Together, they unpack:• Why most people are operating in constant stress without realizing it• How breath directly impacts the nervous system and decision-making• The difference between movement for performance vs movement for healing• Why small, consistent movements create long-term change• How environment (nature, noise, stillness) shapes mental clarity• The importance of finding your own rhythm instead of following rigid systems• How slowing down can actually increase productivity and creativity• Why healing begins internally before it shows externallyThis is not about yoga poses.It's about awareness.Because when you learn how to regulate your breath…you begin to regulate your life.

These episodes of #thePOZcast, live from Transform 2026 in Las Vegas, are proudly brought to you by our friends at Overalls What if your employees had one central hub to handle real life? Meet Overalls. A smarter way to support your team, combining expert human LifeConcierges™ with AI to solve everyday challenges across healthcare, caregiving, benefits, insurance, finances, life admin, and more. From start to finish, Overalls handles the details — using existing benefits where they fit, and filling in the gaps where they don't. So employees save time, reduce stress, and stay focused at work, while employers boost engagement and get more value from their benefits. Overalls is redefining how work supports life, helping employee teams from Reddit, Patreon, BeatBox, and more cross pesky to-dos off their lists every day. Learn more at https://getoveralls.com/?utm_source=podcast&utm_medium=podcast&utm_campaign=pozcast Thanks for listening, and please follow us on Insta @NHPTalent and www.youtube.com/thePOZcast For all episodes, please check out www.thePOZcast.com   CHAPTERS: 00:00 – Introduction & Origin Story Adam and Allie reconnect on camera, sharing how they both landed at Onward Search and what drew them into the world of recruiting. 02:30 – Finding Safety & Belonging at Work Allie opens up about leaving a workplace where she didn't feel safe as a newly out queer person, and how Onward Search welcomed her as she was. 05:00 – Following Your Passion Outside of Work Allie's advice on finding fulfillment outside your day job — and how volunteering for Sofar Sounds led directly to her in-house career at a music company. 07:30 – Agency to In-House: Making the Leap Why going from agency recruiting to in-house felt natural for Allie, and why she believes the agency world is actually the harder direction to go. 10:00 – Output Over Hours: The Remote Work Philosophy A discussion on trust, flexibility, and why giving employees autonomy tends to produce better results — with honest acknowledgment of when it doesn't work. 12:30 – What a VP of People & Culture Actually Does Allie breaks down her remit at SoundCloud: change management, leadership training, org structure, policies, and bridging the gap between managers and the talent team. 15:00 – Building Real Company Values (Not Poster Values) How SoundCloud is approaching values creation from scratch — starting with executive buy-in, pressure-testing with culture keepers, and rolling out with a real adoption plan. 18:30 – Transparency as a Cultural North Star Why Allie believes in a "culture of no surprises" and how leadership transparency — even when imperfect — builds trust across the organization. 21:00 – Personalizing the Candidate & Benefits Experience How great recruiters match candidates to the right benefits by listening carefully during the process — and why benefits like learning stipends, pet insurance, and life concierge services can close competitive offers. 24:00 – SoundCloud's $1,600 L&D Benefit A spotlight on SoundCloud's annual learning and development stipend and why investing in employees' growth pays dividends for the company. 26:30 – Do Recruiters Miss the High of Placing Candidates? Allie and Adam get nostalgic about the rush of closing a deal — and why the feeling of giving someone their dream job never gets old. 29:00 – Navigating Transform 2026 as a First-Timer Allie shares her experience at her first Transform conference and Adam offers tips for making the most of big industry events. 31:00 – What's on Your Playlist? The episode wraps with a music moment — Wet Leg, Alabama Shakes, Chance the Rapper, Fred Again, and a surprise Luke Combs convert. Key Takeaways: 1. Culture of No Surprises Is the Highest Form of Employer Trust The biggest damage to candidate and employee trust comes from being sold a version of a company that doesn't match reality. Allie's north star is radical transparency — leaders sharing hard truths when they can, so employees are never blindsided. 2. Company Values Must Be Built, Not Announced Values that stick don't come from a poster or a company-wide email. They require executive sponsorship, employee pressure-testing, phased rollout, and genuine adoption planning. Anything less is performative — and people know it. 3. Agency Recruiting Is a Training Ground That Makes You Better The discipline of hitting numbers, showing up every day, and working in a high-accountability environment gives agency recruiters a foundation that in-house roles rarely replicate. Allie credits that grind for making her the people leader she is today. 4. Follow Your Passion Outside of Work — It Might Become Your Career Allie's move to SoundCloud started with volunteering for Sofar Sounds on evenings and weekends. Pursuing what you love outside your day job builds relationships, skills, and opportunities you can't manufacture inside an office. 5. Output Over Hours Is the Right Framework — With Guardrails Giving employees trust and flexibility tends to produce exceptional results. But it requires clear expectations, strong manager relationships, and a willingness to coach (or exit) people who aren't built for autonomous work environments. 6. Personalize the Benefits Conversation — Don't Just List the Package The best recruiters listen for what matters to each candidate and connect it to the right benefits. A pet owner lights up when you mention pet insurance. A candidate navigating a same-sex partnership in a complicated state wants to hear about legal concierge support. Benefits close competitive offers when they're presented personally, not generically. 7. L&D Investment Is a Signal of Company Values, Not Just a Perk SoundCloud's $1,600 annual learning and development stipend tells employees: we're invested in your growth, not just your output. For candidates choosing between comparable offers, this kind of benefit signals a culture that takes development seriously. 8. VP of People Is a Bridge Role — Between Managers, Talent, and Leadership Allie's job isn't to recruit or to set policy in a vacuum — it's to sit at the intersection of what managers need, what the talent team is finding, and what leadership is trying to build. The best people leaders are connectors and translators across all three. 9. Feeling Safe at Work Is Non-Negotiable — And Companies That Get It Win Allie's story of leaving a role where she didn't feel safe as a queer person — and finding belonging at Onward Search — is a reminder that psychological safety isn't a soft metric. It's a talent retention and acquisition advantage.    

How does metabolic health govern your long-term vitality, energy, and quality of life? Dr. Priya Jaisinghani outlines why monitoring some basic lifestyle actions could prevent so many common chronic diseases.In this episode of TRUST ME I KNOW WHAT I'M DOING, we sit down with NYU endocrinologist and obesity medicine specialist Dr. Priya Jaisinghani to decode the complexities of metabolic health.Forget the quick fixes and diet culture — Dr. Jaisinghani walks us through a science-backed approach to understanding metabolic function as a comprehensive system. We move beyond the scale to explore how muscle mass, cardiovascular health, and hormonal balance dictate your long-term vitality.In this episode, we cover:• Why "metabolic health" is the true metric for longevity and quality of life.• Actionable steps to improve insulin sensitivity and sustain energy levels.• How to navigate health misinformation and advocate for yourself in the medical system.The critical link between your daily habits—like sleep and hydration—and your organ function.Subscribe for weekly conversations that serve as a mirror and window into the global Indian and South Asian experience.--------------------------Chapters:00:00 Introductions04:07 Defining Metabolic Health07:29 Personalizing the Approach13:03 Bridging Knowledge Gaps in Health16:43 Healthy Choices for Young Adults19:29 Redefining Fun and Social Activities20:40 Empowering Patients as Advocates22:39 Sponsor Break - Travelopod24:06 Tailoring Health Approaches for South Asians28:15 Dismantling Weight Bias and Stigma31:08 Building a Weight Neutral Approach35:01 Understanding GLP-1 Medications37:30 The Role of Nutrition in Metabolic Health39:09 The Importance of Sleep in Metabolic Health40:51 Building Trust in Patient RelationshipsConnect with Dr. Jaisinghanihttps://nyulangone.org/doctors/1942738547/priya-jaisinghaniBig shout outs to Anagha on her 50th, and to my friend, pediatrician colleague, and adolescent medicine guru Dr. Lauren Hartman,  whose latest book Freeing Children and Young Adults from Shame, Scales, and Stigma is available now. Support the Show: If you enjoyed this episode, please subscribe and leave a review on Spotify, Apple, or Amazon or wherever you podcast!TRUST ME I KNOW WHAT I'M DOING is proudly brought to you by TRAVELOPOD, with personalized travel support to help you explore the wonders of the world.  Start your next journey at vacation.travelopod.com

Send us Fan MailOne of the challenges that brands can often face when implementing a loyalty program is getting key stakeholders on the same page about the value of the initiative. More specifically, a chief financial officer and a chief marketing officer might have very different views of the program, with the former seeing it as a cost center while the latter sees it as a growth engine.  A CFO could focus on economics over perks by looking to add expiration policies or increasing redemption thresholds, whereas a CMO is focused on things like personalization, brand engagement, and customer acquisition and retention.  According to David Glantz, Director of Business Development for Germany's Loyalty Partner Solutions (LPS), one of the key ways a CMO can bridge the divide with a CFO is by having the right KPIs in place to effectively argue the value of the program for not just customers, but also the company. KPIs are just one aspect of the program design that LPS helps its partners create.  

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PRZ865. CME/MOC/CC/AAPA/IPCE credit will be available until April 20, 2027.Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PRZ865. CME/MOC/CC/AAPA/IPCE credit will be available until April 20, 2027.Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PRZ865. CME/MOC/CC/AAPA/IPCE credit will be available until April 20, 2027.Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PRZ865. CME/MOC/CC/AAPA/IPCE credit will be available until April 20, 2027.Blocking Type 2 Inflammation in CRSwNP With Targeted Biologic Therapy: Personalizing Care to Achieve Improved Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.

Tom Duncan and Sara Shea continue their journey through Season 1 of The West Wing, this time with episodes 1.19-1.21, exploring key episodes, character relationships, and real-world issues like drug policy and political ethics. Join us as we analyze the final episodes of season one, explore character developments, plot resolutions, and predictions for season two. We also dive into personal preferences for the White House decor and reflect on presidential history.Chapters:00:00 Introduction to First Watch Rewatch02:49 Exploring Episode 19: Let Bartlett Be Bartlett05:35 Character Dynamics and Emotional Tension08:35 The Role of Leadership and Mandates11:32 Thematic Elements of Growth and Confrontation14:22 Character Development: Mandy and the Memo17:28 Political Themes: Gays in the Military and Dark Money20:07 Episode 20: Mandatory Minimums Overview23:02 Character Relationships: Toby and Andy25:42 Romantic Tensions: Josh and Joey28:22 Conclusion and Future Implications31:54 Evolving Perspectives on Drug Use37:23 The Impact of the Opioid Crisis43:06 Rehabilitation vs. Punishment49:12 The Power Dynamics of Criminalization53:33 Cognitive Dissonance in Drug Perception01:04:20 Character Development and Dynamics01:06:25 CJ's Crossroads and Character Growth01:10:09 Cohesion in Storytelling01:11:27 Setting Up for Season Two01:14:35 Guest Appearance and Future Predictions01:22:32 Driving Dynamics and Family Interactions01:23:39 Season Finale Anticipation and Rankings01:24:10 Redesigning the Oval Office01:26:47 Presidential History and Leadership Qualities01:28:38 Chester A. Arthur and Civil Service Reform01:29:58 Personalizing the Presidential Office01:31:54 Memorable Sports Moments and Their ImpactKeywords:The West Wing, political drama, drug policy, campaign finance, character analysis, TV review TV show analysis, season finale, character development, season two predictions, White House decor, presidential history

Joel Sanchez is an American Volleyball coach. A New York product, he played competitively for club Mocha and was a standout at Lehman College. Once he entered coaching, he hit the ground running, with a "Midas touch" on every single program in which he was involved. From club to college to adult pros, wherever there is success, there he is, with a list entirely too long for the description. To date, he is the program director of Legacy Volleyball Club, where his work won him national director of the year in 2022. 04:19 - Legacy volleyball: the idea, the pioneering, the ascension, providing a place of safeness and escapism. 18:22 - NYC being the pandemic ground zero and how the club survived, catching up on 25 years of playing and coaching (for our "people"), being raised in a culture where taking care is first contact is never an issue. 28:28 - Remembering Guillermo Ramos, the hardest hitter we have ever seen, the invincibility of Bameso in 2004-2005, the "beauty" of Desmond "Shadow" Hamilton 38:31 - Why Omar Vargas was the most important coach in NYC from 1994-2004, the majority or NYC coaches in the 2000's were active players with little guidance trying to figure it out - and did they, ever, about Justin Stack, Dan Skillins, Krishna Daas, Danial Levant 52:26 -Personalizing your work: does it work more for you or against you? Plus, how do you set up an environment where people want to come to practice. 1:06:35 - The golden rule of coaching girls and women vs coaching boys and men, plus the moment we realized players changed and we stayed the same, about Jackie Meadow, why do we need a degree to coach? 1:22:22 - finding ways to coach and eat in the South Bronx, plus, more NYC talk, about Elvis Rodriguez, Mike Salak, Seidu Ajanako 1:30:01 - a coach's wild dream is for a player to say they are a better person because of them, and open letter to Joel Sanchez, thanks to the players who picked up the phone and said "yes."

We're doing a short miniseries on the things you NEED to be aware of when using AI. Want to test yourself on how well you can recognize fallacies in real life? Take the Meme Fallacy Quiz! www.filteritthroughabraincell.com/quiz Learn more about Crazy Thinkers membership where you can practice critical thinking using real-life memes, articles & headlines: www.filteritthroughabraincell.com/crazy Here's how you can purchase the Logical Fallacies ebook: https://www.filteritthroughabraincell.com/offers/z6xbAcB2 Send me any questions, comments or even the fallacies you're seeing around you! think@filteritthroughabraincell.com Or, tag me on Instagram: @filteritthroughabraincell Sign up on my email list at: www.filteritthroughabraincell.com/contact Learn more about Women in Apologetics Conference: www.womeninapologetics.com Learn more about Summit ministries: www.summit.org/braincell use code: BRAINCELL26 Learn more about Classical Conversations: www.classicalconversations.com/filterit Thank you to our sponsor, CTC Math! Website: https://www.ctcmath.com/?tr_id=brain Homeschool page: https://www.ctcmath.com/how-it-works/home-school?tr_id=brain Free trail: https://www.ctcmath.com/trial?tr_id=brain Special offer! Get 1/2-off discounts plus bonus 6-months free! Critical Thinking for Teens Logical Fallacies for Teens Cognitive Biases for Teens Homeschool Logic Critical thinking for Middle schoolers

In this episode, Robert Todd Hurst, MD, FACC, FASE delivers a powerful and thought-provoking talk on the real drivers of heart disease and why the current healthcare system often misses the mark. Moving beyond traditional medicine, he explores how stress, habits, leadership, and the pace of modern life quietly shape our long-term health. This episode challenges the idea that heart attacks are inevitable and instead presents a compelling case for prevention through a systems-based approach to healthspan. Drawing from decades of experience in preventive cardiology, Dr. Hurst shares personal stories, clinical insights, and groundbreaking data that reveal how up to 90% of heart disease may be preventable. He breaks down the failures of reactive, one-size-fits-all care and introduces a proactive framework focused on identifying root causes, personalizing strategies, and continuously optimizing health.  Key Timestamps 00:00 – Introduction and keynote context 00:58 – Heart disease as the modern plague 03:18 – The patient story that changed Dr. Hurst's career 05:38 – The evidence that 80–90% of heart disease is preventable 07:58 – Why prevention works in real-world practice 10:22 – Failure #1: Reactive, event-driven healthcare 12:37 – Hidden risk and Dr. Hurst's personal wake-up call 14:59 – Failure #2: One-size-fits-all medicine 17:23 – Personalized care through advanced imaging 19:48 – Failure #3: Disease-focused healthcare 21:46 – The shift from lifespan to healthspan 23:53 – Why preventing disease isn't enough 26:14 – The 3-step system to prevent heart attacks 28:37 – Understanding risk and root causes 30:53 – The overlooked role of stress and mental health 33:13 – The Healthspan framework and key drivers of longevity 35:38 – Personalizing goals and strategies 38:04 – Defend and optimize approach to long-term health 40:28 – Final thoughts: turning back the clock and ending heart disease Connect with Robert Todd Hurst, MD, FACC, FASE here :

Are you adapting to change fast enough or will your industry leave you behind? In this episode of the Real Estate Excellence Podcast, Tracy Hayes sits down with Allison Chance. Allison Chance is a real estate leader military relocation expert and founder of Anchored Real Estate Group who shares her journey of growth leadership and adaptation in an ever-evolving market. She reflects on how her business has transformed over the years the importance of embracing change and how she continues to refine her leadership skills while balancing family life and a growing team. Allison dives into the realities of today's real estate market including pricing strategies buyer behavior and the impact of AI on the industry. She emphasizes the importance of communication relationships and authenticity while leveraging technology wisely. From delegation struggles to navigating difficult negotiations Allison provides a raw and insightful look into what it truly takes to succeed in real estate today. If you want to stay ahead in real estate and business start embracing change refine your strategy and focus on delivering real value to your clients!   Highlights 00:00 - 08:40 Mindset growth and business evolution Staying open to learning Adapting to industry changes Allison's journey and background Growth of Anchored Real Estate Group Balancing family and career 08:40 - 25:10 AI and modern real estate communication Using AI in daily workflow Risks of unedited AI content Maintaining authenticity in messaging Client communication preferences Blending automation with human connection 25:10 - 36:30 Leadership team building and delegation Organic hiring approach Finding the right team fit Mentorship and onboarding Struggles with delegating tasks Building trust within the team 36:30 - 50:45 Systems workflows and client management Text versus phone communication Using automation for efficiency Managing inbound leads Personalizing client experience Staying organized with simple tools 50:45 - 1:20:10 Market trends buyer behavior and pricing Understanding buyer friendly conditions Turnkey versus non turnkey homes Military buyer strategies Using comps and market data Setting realistic seller expectations 1:20:10 - 1:35:52 Negotiation challenges and agent value Handling negotiation standstills Working with other agents effectively Explaining net outcomes to clients Behind the scenes challenges Reinforcing the value of real estate agents   Quotes: "Real estate is evolving every single day and if you are not willing to go with the changes then this probably is not the industry for you." – Allison Chance "AI is not going to replace your job but if you do not embrace AI it will replace you." – Allison Chance "I feel like sometimes I cannot win because no matter what strategy you choose someone will always question it." – Allison Chance "At the end of the day my job is to educate and help my clients make the best decision for their situation." – Allison Chance     To contact Allison Chance, learn more about her business, and make her part of your network, make sure to follow her Website, Instagram, Facebook, YouTube, and LinkedIn.   Connect with Allison Chance! Website: https://anchoredregroup.com/ Instagram: https://instagram.com/thechanceclan Facebook: https://www.facebook.com/allisonhux YouTube: https://www.youtube.com/@allisonchance LinkedIn: https://www.linkedin.com/in/allison-chance-72425a1a/   Connect with me! Website: toprealtorjacksonville.com   Website: toprealtorstaugustine.com    SUBSCRIBE & LEAVE A 5-STAR REVIEW as we discuss real estate excellence with the best of the best.   #RealEstateExcellence #AllisonChance #RealEstate #AIinRealEstate #Leadership #Entrepreneurship #RealEstateAgent #BusinessGrowth #MarketTrends #Negotiation #HomeBuying #HomeSelling #MilitaryFamilies #PropertyInvestment #RealEstateTips #SalesStrategy #ClientExperience #WomenInBusiness #StartupLife #ScalingBusiness #TechInBusiness #Productivity

In this podcast, experts Joyce O'Shaughnessy, MD; Virginia Kaklamani, MD, DSc; and Seth A. Wander, MD, PhD; discuss real-world insights into tailoring adjuvant therapy regimens in hormone receptor–positive/HER2-negative (HR+/HER2–) early breast cancer (eBC).

Get guidance on choosing between raw and cooked foods, keto vs. plant-based, and using elimination diets to personalize your healing journey. #PersonalizedNutrition #EliminationDiet #RawVsCooked #FoodHealing

A patient advocate/cancer survivor and a healthcare professional discuss key topics including early breast cancer diagnosis, role of self-agency in pursuing optimal cancer care, encouraging trial participation with patient testimonials, and other considerations for the patient care journey such as appropriate screening, follow-up encounters for questions, guideline-based treatments, and side effect management.  Participants Kristen D. Whitaker, MD, MS Breast Medical Oncologist Medstar Georgetown Center Institute at Washington Hospital Center Assistant Professor of Medicine Georgetown University School of Medicine Washington, DC Asha Miller Founder, Asha Miller Creative Patient Advocate and Consultant Patient Experience and Health Equity Breast Cancer Veteran Columbus, Ohio Link to full program:https://bit.ly/47XIKV7 Get access to all our new podcasts by subscribing to the Decera Clinical Education Oncology Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Happy birthday season to all the Aries babes out there! This episode is your complete guide to the Libra Full Moon happening today. If you've been feeling the tension between giving and receiving, doing and resting, or pushing and surrendering… this lunar event is here to bring clarity, balance, and closure. Libra is all about relationships, harmony, partnerships, and reciprocity. And this Full Moon is shining a light on where things feel out of balance in your life. Whether that's in your romantic relationships, friendships, business partnerships, family dynamics, or even just the relationship you have with yourself… this moon is asking you to notice what's working, what's not, and where you need to either set boundaries or ask for support. I'll also walk you through how to personalise this Full Moon to your natal chart so you can see exactly which life area is being activated for you right now. In this episode, we dive into: Chapters 00:00:00 Welcome to Aries Season and Libra Full Moon Energy 00:01:32 The Power of Arriving: Finding Peace in the Present 00:02:46 Personalizing This Full Moon Using Your Natal Chart 00:05:16 Connecting Back to the Libra New Moon from October 2024 00:09:56 The Libra Archetype: Love, Balance, and Reciprocity 00:13:13 The Five Love Languages: Speaking Your Partner's Language 00:15:30 Collaboration and Partnerships: Where Can You Ask for Support? 00:16:43 For the Caretakers: Balancing Giving and Receiving 00:17:46 The Mental Load: Sharing Responsibilities and Seeking Recognition 00:20:17 Inner Balance: Masculine and Feminine Energy 00:22:57 Poor Boundaries and Enabling Cycles 00:22:17 Reflection Questions and Closing the Loop There's something so powerful about tracking the lunar cycles and seeing how the seeds we plant six months ago bloom into our current reality. This episode is perfect for anyone who's feeling stretched thin, over giving, under receiving, or just craving more balance and harmony in a certain life area. If you're a caretaker, a parent juggling all the things, an entrepreneur doing it all solo, or someone who just needs to feel more supported… this one's for you. Libra energy isn't about perfection. It's about fairness, reciprocity, and feeling seen for your contribution. So let this Full Moon be your permission slip to ask for help, create boundaries, and let go of what's no longer serving you. ——————

True connection begins with meaningful communication, but in today's digital world, that skill is fading. If you've been craving deeper conversations, this episode is your starting point. We explore transformative strategies to elevate how you communicate and connect. What began as “social distancing” has shaped how we engage, leading to surface-level conversations and limited perspectives. Today, we shift that narrative. This solo episode is designed to bring clarity, structure, and intention back into your relationships. It's powerful, honest, and yes—potentially uncomfortable for some.Welcome to the chart below, to help navigate the best case studies to help build the best communication patterns between men and women! “Hope You Have A Great Day”  In short, it's a polite, friendly statement, but it doesn't naturally spark further conversation unless the other person chooses to respond. Instead of ending with a wish, invite a response:“Hope you have a great day! What are you up to today?”“Hope you have a great day! Any exciting plans?”✅ This keeps the conversation flowing because it asks for input.“Hope You Are Doing Well”  On its own, it does not naturally spark a conversation—it's more of an opening or greeting. ✅ Summary: “Hope you are doing well” is a courteous opener, not a conversation starter by itself.To make it conversational, you need to follow it with a question, context, or personal detail. 1. Add a question about their life or work“Hope you are doing well! How's your week going so far?”“Hope you are doing well! How's work on that project coming along?”✅ Shows genuine interest and invites a response. 2. Reference something specific about them“Hope you are doing well! Did your trip to [city] go as planned?”“Hope you are doing well! How's your new role at [company]?”✅ Personalizing makes it feel less generic and more engaging. 3. Connect over shared experiences“Hope you are doing well! Can you believe how fast this month has gone?”“Hope you are doing well! Did you catch that event we talked about?”✅ Shared context encourages conversation.

This edWeb podcast is sponsored by Renaissance.The edLeader Panel recording can be accessed here.Personalizing learning while maintaining curriculum fidelity is a longstanding challenge in K–12 education. Could the thoughtful use of AI tools hold the solution, helping teams to better connect curricula, assessment, and instruction in every classroom?In this edWeb podcast, join two instructional leaders for the answer, as they explore what a truly connected instructional environment looks like—and how it lightens teachers' cognitive load while promoting more meaningful learning experiences.You also explore:The concept of an Education Intelligence SystemThe growing role of AI in simplifying daily decisionsStrategies for reducing fragmentation between assessment, curricula, and learning toolsHow more coherent systems support whole‑school improvementThis edWeb podcast is of interest to K-12 school leaders, district leaders, and education technology leaders, but will be particularly relevant to superintendents, assistant superintendents, curriculum directors, and assessment directors.RenaissanceAccelerate learning for children and adults of all ability levels and ethnic and social backgrounds.Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Learn more about viewing live edWeb presentations and on-demand recordings, earning CE certificates, and using accessibility features.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TRG865. CME/MOC/AAPA/IPCE credit will be available until March 26, 2027.Personalizing Care for Patients With Prostate Cancer: Collaborative Strategies for Modern Integration of Systemic Therapy In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc., and Bayer HealthCare Pharmaceuticals Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TRG865. CME/MOC/AAPA/IPCE credit will be available until March 26, 2027.Personalizing Care for Patients With Prostate Cancer: Collaborative Strategies for Modern Integration of Systemic Therapy In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas and Pfizer, Inc., and Bayer HealthCare Pharmaceuticals Inc.Disclosure information is available at the beginning of the video presentation.

​What ​if ​you ​could ​tell ​ahead ​of ​time ​who ​needed ​how ​much ​pain ​relief? ​What ​if ​you ​could ​avoid ​administering ​opioids ​to ​those ​with ​the ​highest ​risk ​of ​addiction, ​even ​if ​they ​didn't ​already ​know ​for ​themselves? What ​if ​you ​could ​help ​ease ​the ​pain ​of ​a ​patient ​in ​need ​and ​be ​sure ​that ​you've ​made ​the ​right ​call? Brian ​Meshkin ​of Proove ​Genomics shares his journey from personal tragedy to pioneering a scoring system that helps clinicians assess pain relief needs based on genetic profiles. Discover how this innovative approach aims to mitigate the opioid crisis by identifying patients at risk of addiction and personalizing pain treatment. Join us for an insightful discussion that blends science, compassion, and the urgent need for change in pain management.Find out more at https://proove.com/

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ATW865. CME/MOC/NCPD/AAPA/IPCE credit will be available until March 15, 2027.Charting New Territories in Endometrial Cancer Care: Insights for Personalizing Treatment With Biomarker-Informed Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported through independent medical education grants from GSK and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ATW865. CME/MOC/NCPD/AAPA/IPCE credit will be available until March 15, 2027.Charting New Territories in Endometrial Cancer Care: Insights for Personalizing Treatment With Biomarker-Informed Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported through independent medical education grants from GSK and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ATW865. CME/MOC/NCPD/AAPA/IPCE credit will be available until March 15, 2027.Charting New Territories in Endometrial Cancer Care: Insights for Personalizing Treatment With Biomarker-Informed Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported through independent medical education grants from GSK and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

Is podcast guesting really that different from podcasting hosting? Do you need a PR agency to pitch you? I can't wait to talk about that and more with my friend, author and podcaster Lori Melton. She's sharing about her podcast guesting strategy including how her traditional publisher's publicist played a role, sending her own personalized pitches, and her secret to getting booked on 80% of the shows she pitches.Related episodes:Launch Your Book with a Co-Hosted Podcast SeriesLori's book, Journey with a GiantLori's websiteLori's press kit

Contact John: John@relevantrecovery.orgRecovery literature (quit-lit) recommendations: BreathingUnder Water: Spirituality And The Twelve Steps - https://a.co/d/04c0D2qjBest piece of Recovery Advice: "Trunk to Tail"Resources: https://www.relevantrecovery.org/https://theretreat.org/programs/https://www.hazelden.org/store/welcomehttps://www.marrch.org/Media story on Recovery Ranch: https://thephoenixspirit.com/2024/09/founder-envisions-minnesotas-first-recovery-ranch/https://www.relevantrecovery.org/recovery-ranch/Song that symbolizes recovery: Pentatonix - AmazingGrace (My Chains Are Gone)  - https://youtu.be/Obp-9BEZe1c?si=xe_STqS_S9m5YvO8 TakeawaysJohn Magnuson shares his journey of recovery from alcoholaddiction.Serving the recovery community starts with maintainingpersonal sobriety.Recovery means finding love, happiness, and a sense ofpurpose.Childhood experiences shaped John's understanding ofaddiction.Alcohol was a significant part of John's early life and ledto serious consequences.Navigating early adulthood involved balancing politicalaspirations and addiction.A turning point in John's life led to a deeper understandingof spirituality in recovery.Failure in business prompted a reevaluation of prioritiesand personal growth.Community support is crucial in the recovery process.Embracing change and new directions can lead to unexpectedopportunities. Personalizing recovery pathways is crucial for individualsuccess.Authenticity in communication fosters connection andunderstanding.Humility allows for growth and acceptance in recovery.Peer support has evolved but still needs to adapt to currentneeds.Coaching families can lead to profound transformations inrecovery.Creating a supportive environment is essential for healing.Daily routines play a significant role in sustainablerecovery.Literature can provide valuable insights and guidance inrecovery.Music serves as a powerful tool for healing and expression.Trusting the process and remaining open to change is vital. SummaryIn this conversation, John Magnuson shares his journey ofrecovery from alcohol addiction, emphasizing the importance of serving therecovery community, the evolution of his understanding of recovery, and therole of spirituality in his life. He reflects on his childhood, earlyexperiences with alcohol, and the turning points that led him to embrace a newdirection in life. John discusses the significance of community support, thelessons learned from failure, and the power of personal stories in recovery. Healso addresses the complexities of privilege and the language used in therecovery community, ultimately highlighting the transformative power ofrecovery and personal growth. In this conversation, John Magnuson shares hisinsights on the importance of personalizing recovery pathways, the role ofauthenticity and humility in communication, and the evolution of peer support.He discusses his journey into coaching and the vision behind Relevant Recovery,emphasizing the significance of creating a supportive environment for familiesin recovery. John also highlights the healing power of music and the importanceof daily routines in maintaining recovery. His experiences reflect a deepunderstanding of the spiritual aspects of recovery and the need for communitysupport.Don't forget to check out “The Way Out Playlist” available onlyon Spotify. Curated by all our wonderful guests on the podcast! https://open.spotify.com?episode/07lvzwUq1L6VQGnZuH6OLz?si=3eyd3PxVRWCKz4pTurLcmA (c) 2015 - 2026 The Way Out Podcast | All Rights Reserved. ThemeMusic: “all clear” (⁠⁠⁠https://ketsa.uk/browse-music/)byKetsa (https://ketsa.uk⁠⁠⁠)licensedunderCCBY-NC-ND4.0(https://creativecommons.org/licenses/by-nc-nd)

In this episode of Brave New Bookshelf, hosts Steph Pajonas and Danica Favorite are joined by Kimberly Gordon, the Director of the Ink and Code Society at Future Fiction Academy, to explore her revolutionary "story is code" philosophy. Kimberly shares her unique journey from a military and IT background to becoming a prolific fantasy author, explaining how she leverages coding applications like Antigravity and advanced features like Claude Skills to deeply personalize her writing process. From drafting at incredible speeds to using AI as a vital assistive tool for neurodivergence and preventing author burnout, this conversation highlights how technology can amplify the creative talent already inside every writer. Visit our website https://bravenewbookshelf.com to view the full episode notes, links and apps mentioned in the episode, and the full transcript.

In this episode of Keeping Abreast, Dr. Jenn Simmons is joined by Jen Nolan and Sara Stratton of Remission Nutrition for a conversation that cuts through the noise around “healthy living” after a breast cancer diagnosis.Jen explains how nutrigenomics (genetic-based nutrition + lifestyle guidance) helps women understand what their body actually needs, from detox capacity to fat metabolism to exercise tolerance. Dr. Jenn shares her own example: years of high-intensity endurance workouts that she thought were helping until genetic testing revealed they were doing real harm.Sara shares her story of being diagnosed with stage 3C triple positive breast cancer at 37, and how she supported her body through chemotherapy and recovery using a metabolic approach, including fasting around treatment, strength training, mindfulness, and carefully chosen supplements. Together, they talk about how to make changes without overwhelm, avoid fear-based restriction and orthorexia, navigate resistance from conventional providers, and build a lifestyle that's sustainable long-term - with joy included.In This Episode, You'll Learn:What nutrigenomics can tell you about food, detox, sleep, stress, and exerciseSara's approach to supporting her body during chemo: fasting, movement, mindfulness, and recoveryWhat to know about supplements during chemotherapy including why antioxidants can be trickyWhy people get overwhelmed after diagnosis, and how to start with small, realistic stepsThe “crowding out” method: what to add first so healthy habits stickCommon non-negotiables that move the needle fast (Diet soda + processed snack foods)How to avoid orthorexia and stop turning food into fearHow to advocate for yourself when your oncologist dismisses integrative toolsEpisode Timeline: 01:06 Introducing Jen Nolan + Sara Stratton 04:10 Nutrigenomics and personalized healing 10:56 Sara's diagnosis at 37 + what life looked like before 13:55 Metabolic approach during treatment (fasting, keto, movement) 24:14 Fasting around chemo + how she trained through treatment 28:47 Supplements + what to avoid during chemotherapy 32:11 Fat metabolism genes + why keto doesn't work the same for everyone 35:59 How to start without overwhelm (3 changes at a time) 44:44 Treatment phase vs. long-term lifestyle (graduating from strictness) 49:55 Why conventional providers resist integrative support 51:43 What to do when your oncologist dismisses fasting/nutrition 54:34 Why breast cancer is usually not an emergency (and time matters) 58:48 Joy, purpose, and living while healingTo talk to a member of Dr. Jenn's team and learn more about working privately with Dr. Jenn visit: https://calendly.com/stephanie-1031/clarity-callTo get your copy of Dr. Jenn's book, The Smart Woman's Guide to Breast Cancer, visit: https://tinyurl.com/SmartWomansBreastCancerGuideTo purchase the auria breast cancer screening test go here https://auria.care/ and use the code DRJENN20 for 20% Off.Connect with Dr. Jenn:Website: https://www.jennsimmonsmd.com/Facebook: https://www.facebook.com/DrJennSimmonsInstagram: https://www.instagram.com/drjennsimmons/YouTube: https://www.youtube.com/@dr.jennsimmons

On the podcast: how Duolingo prioritizes clarity over persuasion on their paywalls, why they offer users multiple free trials instead of just one, and how adding friction to their trial reminder flow actually boosted conversions.This conversation is shorter than usual and will be featured in RevenueCat's State of Subscription Apps report. Each episode in this series will explore one crucial topic and share actionable insights from top subscription app operators.Top Takeaways:

What do you do after 197 rejections … for the same book?Well, if you're author Carmela Dutra, you keep going.In this episode, Carmela shares the real story behind her debut cozy mystery, A Murder Most Foul—from querying too soon and rewriting extensively to finding the right agent after nearly 200 nos. We talk about saggy middles, tense slips, brutal feedback, and what it takes to rebuild a manuscript from the ground up.If you're struggling with self-doubt, facing a bunch of rejection, and just feeling like maybe it's time to throw in the towel—this conversation will arm you with what you need to keep going and protect your mindset!Timestamps: 04:20 Personalizing cold queries06:12 What A Murder Most Foul is about11:19 Craft struggles: saggy middles & tense slips15:44 Surviving 197 rejections18:11 Ghosting & rock bottom19:48 Finding the right agent21:42 Learning to plot23:10 Imposter syndrome (“Peggy”)28:37 Querying advice30:20 Finding time to write as a momGuest Bio:Carmela Dutra is a writer from the Bay Area who loves food trucks, family, and cozy mysteries. Her debut, A Murder Most Fowl, has been praised by Kirkus Reviews for its “serious set of crimes leavened by plenty of amusing moments,” by Criminal Element for the “juicy reasoning behind the sabotage that was almost as shocking as the murder itself,” and described as “the perfect escapist read, brimming with banter and an extra helping of fun” by New York Times bestselling author Ellery Adams. She has also been featured in CrimeReads Magazine.To connect with Carmela and purchase her books, visit her website and check her blog series: An Author's Guide to Quering for hot tips!Have a comment or idea about the show? Send me a direct text! Love to hear from you.Support the show To become a supporter of the show, click here!To get in touch with Stacy: Email: Stacy@writeitscared.co https://www.writeitscared.co/wis https://www.instagram.com/writeitscared/ Take advantage of these Free Resources From Write It Scared: Download Your Free Novel Planning and Drafting Quick Start Guide Download Your Free Guide to Remove Creative Blocks and Work Through Fears

Start feeling strong and healthy today- with 100+ of amazing women: https://brittany-pearson-0916.mykajabi.com/joinus-c314ce99-4585-4cae-b251-ccae6f397184/PERSONALIZED WORKOUT OPTIONS: found at the bottom of this page: https://www.healthycatholicmoms.com/services/Start losing fat NOW with this FREE guide: https://mailchi.mp/fbd438cb9e15/free-macro-downloadTry my FREE 3 Day Pregnancy Workout Challenge here: https://mailchi.mp/3544a2978243/threedaypregnancyprogramGet the FREE GUIDE to Exercising Postpartum!https://mailchi.mp/4e93de16eeaf/q047rmh7veMy pregnancy and postpartum programs are ALWAYS available right here:https://www.healthycatholicmoms.com/services/Shop Healthy Catholic Moms merch here! Mugs, shirts, and more...https://www.healthycatholicmoms.com/shop/Join my email list here: https://www.healthycatholicmoms.com/____________________________________________________________________________________Schedule a 30 minute coaching call with me here:https://www.healthycatholicmoms.com/services/____________________________________________________________________________For recipes, workouts, and tips- follow me on:Instagram: https://www.instagram.com/healthycatholicmoms/Facebook: https://www.facebook.com/healthycatholicmomsEmail: brittany@healthycatholicmoms.com

Self-awareness is a superpower. What if ROI meant something entirely different in your sales strategy? Jamie Diglio, founder of The Win Room and former leader at Microsoft and Gartner, stops by to challenge the traditional view of ROI. Instead of focusing on return on investment, Jamie introduces the concept of "return on interactions" and shares how this subtle mindset shift can make every conversation more profitable. Together with Mark Hunter, she reveals why being memorable and present is more vital than ever in a world shaped by AI and information overload. Listeners will get a preview of Jamie's unique frameworks that help sellers and leaders decode how prospects and team members listen. The episode teases practical ways to heighten self-awareness, adapt your style, and break through the noise by tailoring your approach. 

Zarah Fowler is an American volleyball coach and active player. After briefly playing at Coastal Carolina, she redirected her energy to being a coaching savage at the club level, with the ultimate goal of coaching DI and someday directing her own club. Ambition on steroids. 06:48 - How long did it take to separate Zarah the coach from Zarah the player? 13:30 - Are you learning about yourself from coaching (as an active player and...person), plus are you a video nerd? 21:31 - Personalizing your work: the pros and cons 27:01 - What do you tell your team after a tough loss in the middle of the tournament? 31:38 - Why do people leave hating the sport: the parent, player and coaching perspective, understanding the difference between coaching girls and boys, and the ground rules 48:38 - The club system, the paying customer, listening to what the kid wants, present them their reality and options, plus, knowing when to take time off, the difference between coaching hot or cold, the dangers of the former 59:10 - Attitude adjustment stories, and how the deal, and the risk that comes with it 1:08:11 - Controllables, things you can control that the other team cannot take away 1:14:25 - Fundamentals that come across as easy to teach, the value of marketing and networking, tip on being recruited, what the coach's bandwidth of attention is, the dynamic shift on who rules indoor women's volleyball 1:34:15 - are we role models or are we saints? Good reading material, movies that inspire us #nyvarsitysports #optionpodcast #progressionbeachvolleyball

Dr. Monty Pal and Dr. Ari Rosenberg discuss the evolution of treatment strategies in head and neck cancers, including the challenges of treating both HPV-positive and HPV-negative disease and the emergence of blood-based biomarkers to advance personalized therapy across different subtypes. TRANSCRIPT Dr. Monty Pal: Hello and welcome to the ASCO Daily News Podcast. I'm your host, Dr. Monty Pal. I'm a medical oncologist, professor, and vice chair of academic affairs at the City of Hope Comprehensive Cancer Center in Los Angeles. Today, we're going to explore the evolving landscape of treatment strategies in head and neck cancer management, including locoregionally advanced head and neck squamous cell carcinoma, which happens to be on the rise in United States, in part due to spike in HPV-mediated oropharyngeal cancers. We're also going to discuss the emerging strategies of using blood-based biomarkers to really advance personalized therapy. Joining me for this discussion is Dr. Ari Rosenberg. He's a medical oncologist focused on head and neck cancer, and he's an associate professor – congratulations on the recent promotion – at the University of Chicago. The University of Chicago has really produced luminaries in this field, Dr. Rosenberg included. I've had the pleasure of getting to know Dr. Ezra Cohen over the years, who really had his grounding there, and of course Everett Vokes, former ASCO President. I'm really looking forward to this conversation, Ari. Thanks so much for joining us. Dr. Ari Rosenberg: Thanks, Monty. Thanks for the invitation. Dr. Monty Pal: You got it. And just a quick note for our listeners, our full disclosures are going to be in the transcript at the end of this episode. So let's start with the basics, if you don't mind. So, head and neck cancers are very diverse and they're challenging, right? In the sense that they're near vital organs, the treatments, you know, as we all saw during fellowship, if not now in clinical practice. They can really have such a major impact on vital organ function, speech, swallowing, et cetera. Can you just comment on head and neck cancers that are on the rise in the U.S.? I alluded to this briefly. Particularly, we've heard this in the context of colorectal cancer and so forth. Are you actually seeing younger adults being affected by this? Dr. Ari Rosenberg: Yeah, thanks for that. The vast majority of head and neck cancers are head and neck squamous cell carcinomas, as I'm sure many of the listeners recall as well from fellowship or their current training. And as you alluded to, the organ function, long-term and functional quality of life outcomes are quite important, particularly in the context that these develop in high value real estate, parts of our head and neck area that we use for speaking, swallowing, all sorts of other essential functions as well. As you also alluded to, we think of this in two different particular subtypes of head and neck cancer. The historical head and neck cancer from 50, 60 years ago was almost exclusively related to carcinogen exposure, tobacco, alcohol use, and that subtype of carcinogen-induced head and neck cancer has been slowly declining. However, over the last now several decades, we've been seeing an increase in primary oropharyngeal squamous cell carcinoma, mostly tonsil, base of tongue. These are attributable to HPV, human papillomavirus exposure. And that's now the majority of the head and neck cancers that we tend to see in our clinic. As you also alluded to, these have very different prognoses as well. HPV-related head and neck cancer has a much more favorable prognosis where much of the interest has been in can we de-intensify to optimize long-term function? But then the non-HPV-related head and neck cancer, or what we call HPV-negative head and neck cancer, continue to be very, very challenging. We only managed to cure about half of these folks, with many of these patients developing the current disease. These patients, in addition to being difficult to treat, also have major impacts both in terms of the treatments they undergo as well as their disease that can impact their function and quality of life. And you hinted at this a little bit, but we have been seeing an increase in younger patients with HPV-negative head and neck cancer as well, which is quite concerning. Younger patients, oftentimes never smokers, never drinkers, who are developing non-HPV-negative head and neck cancer. And that's been a little bit of a more recent trend that we've been seeing as well. So, definitely a lot of work to be done to optimize and improve outcomes across all of these different head and neck cancer subtypes. Dr. Monty Pal: I mean, I'm just curious, you know, in the context of colorectal cancer, one of the things that we talk about is the potential role of the microbiome driving some of these young-onset cancers with, you know, perhaps there being an impact on, for instance, inflammation and the gut and what have you. Tell me about head and neck cancer. Is this anything known as to why younger patients might be getting diagnosed with non-HPV type cancers? It's odd to me. Dr. Ari Rosenberg: Yeah, it's a great question. A lot of people are working on it. I think we folks have hypotheses, but it hasn't totally panned out exactly what's going on there. It does have a little bit more of a tendency towards women, whereas historically head and neck cancer is much more common in men than it is in women. But lots of people working on that, whether it's related to chronic inflammation, whether it's related to the microbiome. Whether it's related to dental exposure, dental work. So, a lot of folks trying to parse that out because I agree with you, it needs to be identified alongside improving treatment paradigms for these patients, the young ones and the older patients as well. Dr. Monty Pal: Interesting, interesting. You know, one of the phenomena that was sort of coming around when I was in training 25 years ago was this role of sort of induction therapy for head and neck cancers. And of course, it's really come full circle now to include checkpoint inhibitors and so forth. Tell me a little bit about this and how you apply it, maybe in an HPV-mediated context, maybe in a non-HPV context. Dr. Ari Rosenberg: Yeah, absolutely. Induction chemotherapy, as you alluded to, or neoadjuvant chemotherapy, depending on what the locoregional treatment approach is. Similar to other cancer types where systemic control early on has many potential advantages in this setting. Now, in head and neck cancer, even though induction chemotherapy is quite active in head and neck cancer, both HPV-positive and HPV-negative with pretty good response rates. A survival advantage for all comers with local regionally advanced disease remains unproven. There's been two randomized trials, both underpowered, but essentially did not show a survival advantage, showing that induction chemotherapy for all patients with locoregionally advanced and neck cancer can't be justified for a survival advantage. That being said though, there remains a number of potential advantages of giving induction or neoadjuvant chemotherapy, of course, improving systemic control and debulking the disease early on has potential advantages, and predicting the responsiveness to subsequent radiation treatment. We know for some time in head and neck cancer that the percentage of shrinkage or the response to induction chemotherapy actually predicts outcome related to radiation as a dynamic biomarker where response can be used to select patients, for example, for de-escalated radiation has been an area of active investigation, active research. And it also remains a key opportunity to evaluate predictive biomarkers and understanding pre and post treatment to better understand the biology. I'll just add to your question that recently over this past year, we also saw phase 3 data for neoadjuvant immunotherapy for a subset of head and neck cancer that is surgically resectable. And so that's reintroducing the potential benefit in the immunotherapy era of incorporating immunotherapy in the neoadjuvant or the induction setting as part of the evolving treatment paradigm for these diseases. Dr. Monty Pal: That's really interesting. And you kind of alluded to already several topics that I plan to hit on, you know, for instance, the role of immune checkpoint inhibitors, induction, chemotherapy, and so forth. And you started to touch on biomarkers. And of course, I think that's something near and dear to many of us in academic oncology. One thing that we've started talking a lot about in the context of colorectal cancer is circulating tumor DNA. How do you think this might fit in the context of head and neck cancer? Can you give us a flavor for that? Dr. Ari Rosenberg: Yeah, absolutely. In head and neck cancer, the current landscape is most developed for circulating tumor DNA for HPV-related head and neck cancer. The advantage of HPV-related head neck cancer is that you have a distinctive HPV DNA that does tend to spill out into the peripheral blood and can be detected using various different blood-based assays. And because of that advantage as a tissue agnostic approach, it turns out that a number of HPV DNA plasma assays are actually quite sensitive and quite specific. And a number of them have indeed been commercialized. Of course, not only for detecting a baseline, but also grading responsiveness during treatment and probably most importantly in the post-treatment surveillance setting, the detection of HPV DNA in the plasma remains a very important and substantial predictor of developing recurrent disease. There's been a number of trials that have been emerging looking at ctDNA and HPV-related head and neck cancer, using it, for example, as a strategy to deescalate patients. That was something we saw this past ASCO from the Dana-Farber group, and also using it to early detect recurrence and potentially intervene earlier for patients with minimal residual disease positivity. So, that remains evolving and as many folks are, I think, already using it in the clinic. But ctDNA also has a lot of potential for HPV-negative head and neck cancer. This is actually a bit more challenging to develop because you don't have that HPV DNA that you can track predictably because the tumor is an HPV- negative disease are much more heterogeneous, but there are a number of data that are coming out both for personalized assays such as Signatera or some of the other assays that require tumor. Unlike colon cancer, which you referenced, where most patients get surgery upfront, in head and neck cancer, many of the patients receive non-surgical pre-chemoradiation. So sometimes the amount of tumor available to generate a personalized assay is more limited and can be one of the challenges that we see in head neck cancer. But certainly that also seems to be emerging. And there's also further assays that are being developed for HPV-negative head neck cancers, such as methylomic signatures and others that may be tissue informed or tissue agnostic. And these are also emerging, particularly in the post-treatment surveillance setting as strong predictors of recurrent disease. So while we're certainly behind some of these other more common tumor types, colon cancer, lung cancer, we're right there with them and more and more trials are going report out, including a number of trials in our upcoming [University of Chicago] Head and Neck Cancer Symposium where I'll be presenting some data and others in the field will be presenting some data looking at ctDNA both for HPV-positive and for HPV- negative to try to improve outcomes for these patients. Dr. Monty Pal: That's so interesting. I've got to tell you that in kidney cancer, what I deal with day to day is a very low shedding disease, right? So techniques as opposed to ctDNA looking for tumor-informed information, that might be less preferred to something like methylomics where you might not necessarily be so contingent on what's happening in the primary tumor. I'm really interested in you mentioning that. Just a point of clarification, this is something I'm trying to wrap my head around. You'd mentioned circulating tumor HPV DNA, right? I assume this is markedly different from just looking for HPV titers in the patient, right? So is this actually incorporated elements of HPV within, you know, essentially host genome, if you will? Dr. Ari Rosenberg: Yeah, correct. This is circulating tumor HPV DNA. And we think of it biologically as a plasma-based tumor DNA biomarker that's specific for HPV-related head and neck cancers. Dr. Monty Pal: Got it, got it. It makes me wonder whether or not this might be applicable to diseases like cervical cancer and so forth where there's also extensively, you know, biology driven by HPV. Is that fair? Dr. Ari Rosenberg: Yes, definitely. And in the head and neck cancer field, much of this ctDNA actually was derived from a different viral mediated head neck cancer, is less common in the U.S., but nasopharyngeal cancer, which is oftentimes associated with EBV. That has been a biomarker for quite some time in nasopharyngeal cancer. Of course, in places where EBV-associated nasopharyngeal cancer, is endemic, such as East Asia, this has been around for quite some time, but we've been using that in the U.S., and there's been trials that have used EBV DNA plasma to predict recurrence and stratify for adjuvant treatment, for example. And so now with HPV, it's much more applicable to our US population because the vast majority of our head and neck cancer patients that we see in the US that are viral mediated in the US tend to be HPV-related. So having assays that we can use to improve outcomes for that biological subset remains of particular interest for us. Dr. Monty Pal: Yeah, that's fascinating. By the way, for the fellows listening, there's tons of boards pearls here that Dr. Rosenberg shared, EBV-associated cancers, the role of HPV and treatment association. So if you're recertifying anytime soon, I definitely think there's notes to take from this conversation indeed. I wanted to shift gears a little bit. And obviously, you're a prolific researcher. I don't think anyone goes through their fellowship in medical oncology without recounting these experiences of our head and neck patients really suffering from treatment-related toxicities. It's a real challenge. And I'm just wondering, I know a big body of work that you're focused on is really using multimodality treatment paradigms to perhaps reduce the cumulative treatment burden of patients with head and neck cancers. Can you talk about that a little bit? Dr. Ari Rosenberg: Yeah, definitely. Thanks for the question. And before I start going into some of the strategies, I'll just say that head and neck cancer, this is particularly for the fellows that are listening as well, just in reference to your prior comment, that this is really a multidisciplinary disease. At our center, all head and neck cancer patients are seen upfront at that first visit by all three specialties, med onc, rad onc, and surgery, because the choice and sequencing of modalities to optimize not only survival, but also functional quality of life outcome is so critical. And I think that's probably the biggest takeaway for anyone who treats a lot of head and neck cancer or will be treating a lot of head and neck cancer in the clinic. But in terms of more specific attempts at trying to optimize some of those parameters that you described, we really think about these separately in terms of HPV-positive and HPV-negative head and neck cancer. For HPV-positive head and neck cancer, the cure rates are quite high with chemo radiation, although not for everyone. There's still about 15, 10 to 15 % of folks that will develop a recurrence. But for the vast majority of patients, standard chemoradiation is quite a cure to therapy, but the toxicity associated with that can be quite substantial. And so there's been a number of attempts to try to deescalate treatment. It turns out that deescalating everyone with locoregionally advanced HPV-positive head and neck cancer is not a good strategy because it's not able to select out the patients that really do need full dose treatment. And we have seen some negative trials that show inferior outcomes when everyone is deescalated. But what does remain promising is again, trying to select out who the best candidates are for deescalated treatment. The folks at MSK have hypoxia imaging that they're using in trials that looks quite promising to select for the more favorable deescalatable biology. At our center, we've been interested in using induction chemotherapy to stratify response and select patients for deescalated treatment with excellent survival outcomes and reduce toxicity with deescalated treatment. And more recently, ctDNA that us and other groups, such as the Dana-Farber group, is using. And that also looks quite promising. Again, how do you select the patient who will do well with less radiation versus the ones that really need the full doses and volumes of radiation? And then for HPV-negative head and neck cancer, this is a much trickier disease because already the survival outcomes are not like we want it to be. Trying to figure out how to improve survival outcomes remains an important thing. Using immunotherapy seems to be one of the key cornerstones to that. But these are patients that also suffer from a lot of toxicity related to their treatment. We completed a trial not too long ago that we published this past year where we, in HPV-negative head and neck cancer patients, de-intensified the radiation for responders to neoadjuvant chemoimmunotherapy. And those patients did similar, if not even a little bit better, than the non-responders who got full dose treatment. So something that does warrant further investigation as well. How do we not only improve survival for those patients, but also reduce some of the long-term toxicities? Dr. Monty Pal: This is brilliant. I'm taking so many notes as you were mentioning these items. There are so many areas where I think the research crosses over. I already mentioned, know, ctDNA, for instance, and metabolomics and the places where that might apply to kidney cancer. The hypoxia imaging really caught my ear too. Obviously, kidney cancer is disease highly predicated on hypoxia. So thank you for all of this. We've got about a minute or so. So, I'm going to ask you for a really tall task here. Can you tell us what you foresee being some of the biggest challenges that sort of lie ahead and head and neck cancer. You've already kind of alluded to it with ongoing research, but if you had to pick maybe 2, 3 problems, the very most that we really need to get to and head and neck cancer, what would that be? Dr. Ari Rosenberg: Yeah, that's a great question. Obviously, lots of things to be done, but if I'm going to limit it to just a couple, I would say number one is really trying to improve the survival for HPV negative local regionally advanced head and neck cancer. We talked early on about how we are seeing, you know, of course we see many of these people that were smokers and drinkers, but also seeing these in younger patients, in patients without a history of tobacco use. Some of these are very biologically aggressive and we need better treatments beyond surgery, beyond chemo radiation, beyond immunotherapy to improve outcomes for these patients and cure more of them. So, I would say that's one big area. And the other is, which we didn't speak about so much in this talk, but remains one of the biggest challenges that we see in the clinic is the recurrent metastatic head and neck cancer patients. This is an incredibly challenging disease to treat, not only with poor survival, but also with substantial impacts on quality of life and function. mean, these are bad recurrences that cause a lot of pain, functional deficits, really impacts quality of life as well. So developing novel therapies, many of which are currently in clinical trials and many of which are currently continuing to be developed, remains so critical. How do we develop better systemic therapies, better targeted therapies, better biomarkers for recurrent metastatic head neck cancer to improve their survival and quality of life and functional outcomes. Those are the two big areas that require the most work at this time within the head and neck cancer field. Dr. Monty Pal: That's brilliant. I mean, I have to tell you I could probably talk to you all day about this, such a fascinating topic. It's a very exciting time in the field. Thank you, Dr. Rosenberg, for all your incredible contributions and thanks for sharing with us your insights on the ASCO Daily News Podcast. Dr. Ari Rosenberg: Yeah, and thanks for the introduction. Hope to do it again soon. Dr. Monty Pal: And many thanks to our listeners for your time today. If you value the insights that you hear from the ASCO Daily News Podcast, please take a moment to rate, review, and subscribe wherever you get your podcasts. More on today's speakers:      Dr. Monty Pal   @montypal  Dr. Ari Rosenberg @AriRosenbergMD Follow ASCO on social media:           ASCO on X     ASCO on Bluesky          ASCO on Facebook           ASCO on LinkedIn           Disclosures:        Dr. Monty Pal:       Speakers' Bureau: MJH Life Sciences, IntrisiQ, Peerview      Research Funding (Inst.): Exelixis, Merck, Osel, Genentech, Crispr Therapeutics, Adicet Bio, ArsenalBio, Xencor, Miyarsian Pharmaceutical      Travel, Accommodations, Expenses: Crispr Therapeutics, Ipsen, Exelixis  Dr. Ari Rosenberg:     Stock and Other Ownership Interests: Privo Technologies Consulting or Advisory Role: Nanobiotix, EMD Serono, Vaccitech, Novartis, Eisai, Astellas Pharma, Regeneron, RAPT Therapeutics, Geovax Labs, Janssen, Summit Therapeutics Speakers' Bureau: Coherus Biosciences Research Funding (Inst.): Hookipa Biotech, EMD Serono, Purple Biotech, Bristol-Myers Squibb/Celgene, BeiGene, Abbvie, Astellas Pharma, Pfizer, Janux Therapeutics

This talk was given by Gil Fronsdal on 2026.02.13 at the Insight Meditation Center in Redwood City, CA. ******* A machine generated transcript of this talk is available. It has not been edited by a human, so errors will exist. Download Transcript: https://www.audiodharma.org/transcripts/24442/download ******* For more talks like this, visit AudioDharma.org ******* If you have enjoyed this talk, please consider supporting AudioDharma with a donation at https://www.audiodharma.org/donate/. ******* This talk is licensed by a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License

This talk was given by Gil Fronsdal on 2026.02.13 at the Insight Meditation Center in Redwood City, CA. ******* A machine generated transcript of this talk is available. It has not been edited by a human, so errors will exist. Download Transcript: https://www.audiodharma.org/transcripts/24442/download ******* For more talks like this, visit AudioDharma.org ******* If you have enjoyed this talk, please consider supporting AudioDharma with a donation at https://www.audiodharma.org/donate/. ******* This talk is licensed by a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License

In this episode, I welcome back Dr. Krista Leh, instructional coach, former high school educator, and founder of Resonance Education, to explore what it really means to personalize learning resources through an SEL lens. You'll also hear practical examples of how teachers can use student interests, relationships, and even AI tools to make academic content more meaningful, motivating, and relevant for individual learners. If you're interested in personalizing learning resources in ways that feel doable, authentic, and impactful for students and families, this episode has you covered! Show notes: https://classtechtips.com/2026/01/30/personalizing-learning-resources-bonus/ Sponsored by Jotform:  https://jotform.com/enterprise/education/ Follow Dr. Krista Leh on social: https://www.instagram.com/resonance_ed/ Follow Monica on Instagram: https://www.instagram.com/classtechtips/  Take your pick of free EdTech resources: https://classtechtips.com/free-stuff-favorites/   

Happy New Year! In this episode of Marni On The Move, Marni is joined by Jordan Glenn, Head of Science at SuppCo for a conversation on trust, transparency, and personalization in the supplement space. After more than a decade of navigating supplements for performance and long-term health, Marni knows how confusing the industry can be. Jordan shares how SuppCo is helping raise the standard by vetting supplement brands, evaluating formulations and delivery methods, and guiding people toward smarter, more personalized supplement decisions. Jordan sheds light on how to  think about supplement protocols, what actually matters when choosing products, and why personalized stacks—rather than one-size-fits-all solutions—are becoming the future of supplementation. We talk Peptides, NAD+, Creatine, Protein and more!  If you want to feel more confident about what you're taking and why, this episode offers clarity without the hype. Here are a few topics we cover: What SuppCo is and why it exists How supplement brands are vetted Personalizing supplement stacks Cutting through supplement marketing noise Trending supplements and performance considerations How to use SuppCo CONNECT SuppCo on Instagram Marni On The Move Instagram, TikTok, LinkedIn, or YouTube` Marni Salup on Instagram and Playlist on Spotify SUBSCRIBE TO OUR NEWSLETTER Sign up for our monthly newsletter, Do What Moves You, for Marni on the Move updates, exclusive offers, invites to events, and exciting news! SUPPORT THE PODCAST Leave us a five stars and a review on Apple, it's easy, scroll through the episode list on your podcast app, click on five stars, click on leave a review, and share what you love about the conversations you're listening to. Tell your friends the episodes you are listening to on your social. Share a screen shot of the episode in your stories, tag us, we will tag you back!